Skip to main content

Ina Choi

Korea University · 医学

研究室紹介

Professor Ina Choi's research lab specializes in maternal-fetal medicine, with a primary focus on preventing preterm birth through hormonal therapies. The lab investigates the efficacy and mechanisms of progestogen treatments—particularly vaginal micronised progesterone and intramuscular 17α-hydroxyprogesterone caproate—in high-risk pregnant women. Their work combines clinical trials with systematic reviews and meta-analyses to inform evidence-based obstetric practice. The lab is dedicated to improving perinatal outcomes through targeted, biologically informed interventions.

preterm birthprogesterone therapyperinatal outcomesrandomized controlled trialcervical insufficiency

Research Overview

Papers
1
Total Citations
10
Papers (5y)
1
Primary Field
医学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
1total
2020
Citations per year (5y)
10total
2020

Selected Papers

1
1
Article|10 citations·2020
Vaginal compared with intramuscular progestogen for preventing preterm birth in high‐risk pregnant women (VICTORIA study): a multicentre, open‐label randomised trial and meta‐analysis
S‐J Choi, DW Kwak, Kicheol Kil, S‐C Kim, J‐Y Kwon, YH Kim, YH Kim, Sungwon Na, J‐G Bae, H.-H. Cha, J‐Y Shim, KY Oh
SJR Q1BJOG An International Journal of Obstetrics & GynaecologyOA

OBJECTIVE: To compare the efficacy of two types of progestogen therapy for preventing preterm birth (PTB) and to review the relevant literature. DESIGN: A multicentre, randomised, open-label, equivalence trial and a meta-analysis. SETTING: Tertiary referral hospitals in South Korea. POPULATION: Pregnant women with a history of spontaneous PTB or short cervical length (<25 mm). METHODS: Eligible women were screened and randomised at 16-22 weeks of gestation to receive either 200 mg of vaginal mic

EpidemiologyMedicine

Research Areas

Epidemiology

Ina Choiの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。